AMPHASTAR PHARMACEUTICALS, INC.

Analyst Reco. Amphastar Pharmaceuticals, Inc.

Equities

AMPH

US03209R1032

Delayed Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
38.56 ^USD	+2.61%		-3.67%	-37.66%

Jul. 01	Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) added to Russell 2000 Dynamic Index	CI
Jun. 04	Amphastar Pharmaceuticals, Inc. Approves the Appointment of Howard Lee as Director	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

JPMorgan Initiates Amphastar Pharmaceuticals With Overweight Rating, Price Target is $60	Mar. 05	MT
BofA Securities Initiates Amphastar Pharmaceuticals at Neutral Rating With $63 Price Target	Nov. 17	MT
Jefferies Reinstates Buy Rating on Amphastar Pharmaceuticals With $70 Price Target	23-07-25	MT
Wells Fargo Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $40, Maintains Equal-Weight Rating	23-05-17	MT
Piper Sandler Adjusts Amphastar Pharmaceuticals' Price Target to $40 From $43, Keeps Overweight Rating	22-10-25	MT
Jefferies Assumes Amphastar Pharmaceuticals at Buy with $36 Price Target	22-10-21	MT
Capital One Initiates Amphastar Pharmaceuticals at Overweight Rating With $44 Price Target	22-07-29	MT
Northland Adjusts Price Target on Amphastar Pharmaceuticals to $43 From $33, Keeps Outperform Rating	22-04-11	MT
Piper Sandler Raises Price Target for Amphastar Pharmaceuticals to $47 From $35, Maintains Overweight Rating	22-04-08	MT
Wells Fargo Adjusts Amphastar Pharmaceuticals' Price Target to $32 From $23, Keeps Equalweight Rating	22-03-15	MT
Piper Sandler Adjusts Price Target on Amphastar Pharmaceuticals to $35 From $28, Reiterates Overweight Rating	22-03-11	MT
Piper Sandler Upgrades Amphastar Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $28 From $21	22-01-07	MT
AMPHASTAR PHARMACEUTICALS : Wells Fargo Adjusts Price Target on Amphastar Pharmaceuticals to $20 From $21, Maintains Equal-Weight Rating	21-03-17	MT
AMPHASTAR PHARMACEUTICALS : Wells Fargo Downgrades Amphastar Pharmaceuticals to Equal-Weight From Overweight; Price Target is $21	21-01-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Protect and grow your investments with the help of our experts

Securing my Investments

fermer